Currently, Morpho (MORPHO) is trading at $1.13, reflecting a 24-hour decline of 5.05%. The daily price range has been relatively narrow, with a high of $1.20 and a low of $1.086, indicating subdued trading activity amid a market cap volume ratio of 9.97%.

The short-term moving averages present mixed signals; the 8 SMA is at $1.14 (-1.27%), and the 13 SMA is slightly below at $1.13 (-0.07%). However, longer moving averages such as the 55 SMA at $1.18 and the 144 SMA at $1.20 show a more pronounced downward trend, with declines of 4.29% and 5.96% respectively.

Both the 1-hour RSI at 47 and the 7-day RSI at 45 suggest that Morpho is in a neutral to slightly oversold condition. This is compounded by a 7-day price change of -5.63% and a more significant 14-day decline of -13.98%, indicating ongoing bearish sentiment.

In contrast, the 30-day price change shows a modest gain of 2.17%, hinting at some underlying resilience in the longer term. Nonetheless, the significant distance from the all-time high of $4.17, reached in January 2025, underscores the current bearish trend, with the price down over 73% from that peak.

Given the current technical indicators and recent price action, the outlook for Morpho is bearish in the short term. The combination of declining moving averages, negative price momentum, and low RSI readings indicates a high probability of further downward movement.

Overall, I recommend a Sell rating for Morpho (MORPHO) due to the persistent bearish trends and lack of strong buying signals in the immediate market conditions. Investors should consider reallocating funds to avoid potential losses as the asset struggles to regain upward momentum.